Global Personalized Medicine Market Research Report 2025(Status and Outlook)

March 2025 | 232 pages | ID: GA0D27CA5064EN
Bosson Research

US$ 3,680.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question


Report Overview

Individualized medication, medication 'vary from person to person' , give full consideration to each patient's genetic factors, gender, age, body weight, physiological and pathological characteristics, and are taking Others drugs on the basis of the comprehensive situation of safe, reasonable, effective and economic drug treatment.

This report provides a deep insight into the global Personalized Medicine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Personalized Medicine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Personalized Medicine market in any manner.

Global Personalized Medicine Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Abbott Laboratories

Agilent Technologies

Amgen

Astellas Pharma

Astrazeneca

Bayer AG

Celgene Corporation

Glaxosmithkline Plc

Illumina

Johnson & Johnson

Laboratory Corporation

Merck

Novartis AG

Roche Holding AG

Siemens AG

Takeda Pharmaceutical Company Limited

Market Segmentation (by Type)

Personalized Medicine Diagnostics

Personalized Medical Care

Personalized Medicine Therapeutics

Personalized Nutrition and Wellness

Market Segmentation (by Application)

Oncology

Central Nervous System (CNS)

Immunology

Respiratory

Others Applications

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Personalized Medicine Market
  • Overview of the regional outlook of the Personalized Medicine Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Personalized Medicine Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Personalized Medicine
1.2 Key Market Segments
1.2.1 Personalized Medicine Segment by Type
1.2.2 Personalized Medicine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Global Personalized Medicine Market Overview
2.1 Global Market Overview
2.1.1 Global Personalized Medicine Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Personalized Medicine Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Global Personalized Medicine Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Personalized Medicine Product Life Cycle
3.3 Global Personalized Medicine Sales by Manufacturers (2020-2025)
3.4 Global Personalized Medicine Revenue Market Share by Manufacturers (2020-2025)
3.5 Personalized Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Personalized Medicine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Personalized Medicine Manufacturing Sites, Area Served, Product Type
3.8 Personalized Medicine Market Competitive Situation and Trends
3.8.1 Personalized Medicine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Personalized Medicine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Personalized Medicine Industry Chain Analysis
4.1 Personalized Medicine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Personalized Medicine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Personalized Medicine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Personalized Medicine Market
5.7 ESG Ratings of Leading Companies
6 Global Personalized Medicine Market by Region
6.1 Global Personalized Medicine Market Size by Region
6.1.1 Global Personalized Medicine Market Size by Region
6.1.2 Global Personalized Medicine Market Size Market Share by Region
6.2 Global Personalized Medicine Sales by Region
6.2.1 Global Personalized Medicine Sales by Region
6.2.2 Global Personalized Medicine Sales Market Share by Region
7 North America Market Overview
7.1 North America Personalized Medicine Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Personalized Medicine Market Size by Type
7.3 North America Personalized Medicine Market Size by Application
8 Europe Market Overview
8.1 Europe Personalized Medicine Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Personalized Medicine Market Size by Type
8.3 Europe Personalized Medicine Market Size by Application
9 Asia-Pacific Market Overview
9.1 Asia-Pacific Personalized Medicine Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Personalized Medicine Market Size by Type
9.3 Asia-Pacific Personalized Medicine Market Size by Application
10 South America Market Overview
10.1 South America Personalized Medicine Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Personalized Medicine Market Size by Type
10.3 South America Personalized Medicine Market Size by Application
11 Middle East and Africa Market Overview
11.1 Middle East and Africa Personalized Medicine Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Personalized Medicine Market Size by Type
11.3 Middle East and Africa Personalized Medicine Market Size by Application
12 Personalized Medicine Market Production by Region
12.1 Global Production of Personalized Medicine by Region(2020-2025)
12.2 Global Personalized Medicine Revenue Market Share by Region (2020-2025)
12.3 Global Personalized Medicine Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Personalized Medicine Production
12.4.1 North America Personalized Medicine Production Growth Rate (2020-2025)
12.4.2 North America Personalized Medicine Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Personalized Medicine Production
12.5.1 Europe Personalized Medicine Production Growth Rate (2020-2025)
12.5.2 Europe Personalized Medicine Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Personalized Medicine Production (2020-2025)
12.6.1 Japan Personalized Medicine Production Growth Rate (2020-2025)
12.6.2 Japan Personalized Medicine Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Personalized Medicine Production (2020-2025)
12.7.1 China Personalized Medicine Production Growth Rate (2020-2025)
12.7.2 China Personalized Medicine Production, Revenue, Price and Gross Margin (2020-2025)
13 Personalized Medicine Market Segmentation by Type
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Personalized Medicine Sales Market Share by Type (2020-2033)
13.3 Global Personalized Medicine Market Size Market Share by Type (2020-2033)
13.4 Global Personalized Medicine Price by Type (2020-2033)
14 Personalized Medicine Market Segmentation by Application
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Personalized Medicine Market Sales by Application (2020-2033)
14.3 Global Personalized Medicine Market Size (M USD) by Application (2020-2033)
14.4 Global Personalized Medicine Sales Growth Rate by Application (2020-2033)
15 Key Companies Profile
15.1 Abbott Laboratories
15.1.1 Abbott Laboratories Basic Information
15.1.2 Abbott Laboratories Personalized Medicine Product Overview
15.1.3 Abbott Laboratories Personalized Medicine Product Market Performance
15.1.4 Abbott Laboratories Business Overview
15.1.5 Abbott Laboratories SWOT Analysis
15.1.6 Abbott Laboratories Recent Developments
15.2 Agilent Technologies
15.2.1 Agilent Technologies Basic Information
15.2.2 Agilent Technologies Personalized Medicine Product Overview
15.2.3 Agilent Technologies Personalized Medicine Product Market Performance
15.2.4 Agilent Technologies Business Overview
15.2.5 Agilent Technologies SWOT Analysis
15.2.6 Agilent Technologies Recent Developments
15.3 Amgen
15.3.1 Amgen Basic Information
15.3.2 Amgen Personalized Medicine Product Overview
15.3.3 Amgen Personalized Medicine Product Market Performance
15.3.4 Amgen Business Overview
15.3.5 Amgen SWOT Analysis
15.3.6 Amgen Recent Developments
15.4 Astellas Pharma
15.4.1 Astellas Pharma Basic Information
15.4.2 Astellas Pharma Personalized Medicine Product Overview
15.4.3 Astellas Pharma Personalized Medicine Product Market Performance
15.4.4 Astellas Pharma Business Overview
15.4.5 Astellas Pharma Recent Developments
15.5 Astrazeneca
15.5.1 Astrazeneca Basic Information
15.5.2 Astrazeneca Personalized Medicine Product Overview
15.5.3 Astrazeneca Personalized Medicine Product Market Performance
15.5.4 Astrazeneca Business Overview
15.5.5 Astrazeneca Recent Developments
15.6 Bayer AG
15.6.1 Bayer AG Basic Information
15.6.2 Bayer AG Personalized Medicine Product Overview
15.6.3 Bayer AG Personalized Medicine Product Market Performance
15.6.4 Bayer AG Business Overview
15.6.5 Bayer AG Recent Developments
15.7 Celgene Corporation
15.7.1 Celgene Corporation Basic Information
15.7.2 Celgene Corporation Personalized Medicine Product Overview
15.7.3 Celgene Corporation Personalized Medicine Product Market Performance
15.7.4 Celgene Corporation Business Overview
15.7.5 Celgene Corporation Recent Developments
15.8 Glaxosmithkline Plc
15.8.1 Glaxosmithkline Plc Basic Information
15.8.2 Glaxosmithkline Plc Personalized Medicine Product Overview
15.8.3 Glaxosmithkline Plc Personalized Medicine Product Market Performance
15.8.4 Glaxosmithkline Plc Business Overview
15.8.5 Glaxosmithkline Plc Recent Developments
15.9 Illumina
15.9.1 Illumina Basic Information
15.9.2 Illumina Personalized Medicine Product Overview
15.9.3 Illumina Personalized Medicine Product Market Performance
15.9.4 Illumina Business Overview
15.9.5 Illumina Recent Developments
15.10 Johnson and Johnson
15.10.1 Johnson and Johnson Basic Information
15.10.2 Johnson and Johnson Personalized Medicine Product Overview
15.10.3 Johnson and Johnson Personalized Medicine Product Market Performance
15.10.4 Johnson and Johnson Business Overview
15.10.5 Johnson and Johnson Recent Developments
15.11 Laboratory Corporation
15.11.1 Laboratory Corporation Basic Information
15.11.2 Laboratory Corporation Personalized Medicine Product Overview
15.11.3 Laboratory Corporation Personalized Medicine Product Market Performance
15.11.4 Laboratory Corporation Business Overview
15.11.5 Laboratory Corporation Recent Developments
15.12 Merck
15.12.1 Merck Basic Information
15.12.2 Merck Personalized Medicine Product Overview
15.12.3 Merck Personalized Medicine Product Market Performance
15.12.4 Merck Business Overview
15.12.5 Merck Recent Developments
15.13 Novartis AG
15.13.1 Novartis AG Basic Information
15.13.2 Novartis AG Personalized Medicine Product Overview
15.13.3 Novartis AG Personalized Medicine Product Market Performance
15.13.4 Novartis AG Business Overview
15.13.5 Novartis AG Recent Developments
15.14 Roche Holding AG
15.14.1 Roche Holding AG Basic Information
15.14.2 Roche Holding AG Personalized Medicine Product Overview
15.14.3 Roche Holding AG Personalized Medicine Product Market Performance
15.14.4 Roche Holding AG Business Overview
15.14.5 Roche Holding AG Recent Developments
15.15 Siemens AG
15.15.1 Siemens AG Basic Information
15.15.2 Siemens AG Personalized Medicine Product Overview
15.15.3 Siemens AG Personalized Medicine Product Market Performance
15.15.4 Siemens AG Business Overview
15.15.5 Siemens AG Recent Developments
15.16 Takeda Pharmaceutical Company Limited
15.16.1 Takeda Pharmaceutical Company Limited Basic Information
15.16.2 Takeda Pharmaceutical Company Limited Personalized Medicine Product Overview
15.16.3 Takeda Pharmaceutical Company Limited Personalized Medicine Product Market Performance
15.16.4 Takeda Pharmaceutical Company Limited Business Overview
15.16.5 Takeda Pharmaceutical Company Limited Recent Developments
16 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Personalized Medicine Market Size by Type (M USD)
Table 4. Global Personalized Medicine Market Size by Application (M USD)
Table 5. Personalized Medicine Market Size Comparison by Region (M USD)
Table 6. Global Personalized Medicine Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Personalized Medicine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Personalized Medicine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Personalized Medicine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicine as of 2024)
Table 11. Global Market Personalized Medicine Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Personalized Medicine Manufacturing Sites and Area Served
Table 13. Manufacturers Personalized Medicine Product Type
Table 14. Global Personalized Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Personalized Medicine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Personalized Medicine Market Size Comparison by Region (M USD)
Table 26. Global Personalized Medicine Market Size by Region (2020-2033) & (M USD)
Table 27. Global Personalized Medicine Market Size Market Share by Region (2020-2033)
Table 28. Global Personalized Medicine Sales by Region (2020-2033) & (K Units)
Table 29. Global Personalized Medicine Sales Market Share by Region (2020-2033)
Table 30. North America Personalized Medicine Market Size by Country (2020-2033) & (M USD)
Table 31. North America Personalized Medicine Sales by Country (2020-2033) & (K Units)
Table 32. North America Personalized Medicine Sales by Type (K Units)
Table 33. North America Personalized Medicine Market Size by Type (M USD)
Table 34. North America Personalized Medicine Sales (K Units) by Type (2020-2033)
Table 35. North America Personalized Medicine Market Size (M USD) by Type (2020-2033)
Table 36. North America Personalized Medicine Sales by Application (K Units)
Table 37. North America Personalized Medicine Market Size by Application (M USD)
Table 38. North America Personalized Medicine Sales (K Units) by Application (2020-2033)
Table 39. North America Personalized Medicine Market Size (M USD) by Application (2020-2033)
Table 40. Europe Personalized Medicine Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Personalized Medicine Sales by Country (2020-2033) & (K Units)
Table 42. Europe Personalized Medicine Sales by Type (K Units)
Table 43. Europe Personalized Medicine Market Size by Type (M USD)
Table 44. Europe Personalized Medicine Sales (K Units) by Type (2020-2033)
Table 45. Europe Personalized Medicine Market Size (M USD) by Type (2020-2033)
Table 46. Europe Personalized Medicine Sales by Application (K Units)
Table 47. Europe Personalized Medicine Market Size by Application (M USD)
Table 48. Europe Personalized Medicine Sales (K Units) by Application (2020-2033)
Table 49. Europe Personalized Medicine Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Personalized Medicine Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Personalized Medicine Sales by Country (2020-2025) & (K Units)
Table 52. Asia-Pacific Personalized Medicine Sales by Type (K Units)
Table 53. Asia-Pacific Personalized Medicine Market Size by Type (M USD)
Table 54. Asia-Pacific Personalized Medicine Sales (K Units) by Type (2020-2033)
Table 55. Asia-Pacific Personalized Medicine Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Personalized Medicine Sales by Application (K Units)
Table 57. Asia-Pacific Personalized Medicine Market Size by Application (M USD)
Table 58. Asia-Pacific Personalized Medicine Sales (K Units) by Application (2020-2033)
Table 59. Asia-Pacific Personalized Medicine Market Size (M USD) by Application (2020-2025)
Table 60. South America Personalized Medicine Market Size by Country (2020-2033) & (M USD)
Table 61. South America Personalized Medicine Sales by Country (2020-2033) & (K Units)
Table 62. South America Personalized Medicine Sales by Type (K Units)
Table 63. South America Personalized Medicine Market Size by Type (M USD)
Table 64. South America Personalized Medicine Sales (K Units) by Type (2020-2033)
Table 65. South America Personalized Medicine Market Size (M USD) by Type (2020-2033)
Table 66. South America Personalized Medicine Sales by Application (K Units)
Table 67. South America Personalized Medicine Market Size by Application (M USD)
Table 68. South America Personalized Medicine Sales (K Units) by Application (2020-2033)
Table 69. South America Personalized Medicine Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Personalized Medicine Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Personalized Medicine Sales by Country (2020-2033) & (K Units)
Table 72. Middle East and Africa Personalized Medicine Sales by Type (K Units)
Table 73. Middle East and Africa Personalized Medicine Market Size by Type (M USD)
Table 74. Middle East and Africa Personalized Medicine Sales (K Units) by Type (2020-2033)
Table 75. Middle East and Africa Personalized Medicine Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Personalized Medicine Sales by Application (K Units)
Table 77. Middle East and Africa Personalized Medicine Market Size by Application (M USD)
Table 78. Middle East and Africa Personalized Medicine Sales (K Units) by Application (2020-2033)
Table 79. Middle East and Africa Personalized Medicine Market Size (M USD) by Application (2020-2033)
Table 80. Global Personalized Medicine Production (K Units) by Region(2020-2025)
Table 81. Global Personalized Medicine Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Personalized Medicine Revenue Market Share by Region (2020-2025)
Table 83. Global Personalized Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. North America Personalized Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Europe Personalized Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Japan Personalized Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. China Personalized Medicine Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Global Personalized Medicine Sales by Type (K Units)
Table 89. Global Personalized Medicine Market Size by Type (M USD)
Table 90. Global Personalized Medicine Sales (K Units) by Type (2020-2033)
Table 91. Global Personalized Medicine Sales Market Share by Type (2020-2033)
Table 92. Global Personalized Medicine Market Size (M USD) by Type (2020-2033)
Table 93. Global Personalized Medicine Market Size Share by Type (2020-2033)
Table 94. Global Personalized Medicine Sales (K Units) by Application
Table 95. Global Personalized Medicine Market Size by Application(M USD)
Table 96. Global Personalized Medicine Sales by Application (2020-2033) & (K Units)
Table 97. Global Personalized Medicine Sales Market Share by Application (2020-2033)
Table 98. Global Personalized Medicine Market Size by Application (2020-2033) & (M USD)
Table 99. Global Personalized Medicine Market Share by Application (2020-2033)
Table 100. Global Personalized Medicine Sales Growth Rate by Application (2020-2033)
Table 101. Abbott Laboratories Basic Information
Table 102. Abbott Laboratories Personalized Medicine Product Overview
Table 103. Abbott Laboratories Personalized Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Abbott Laboratories Business Overview
Table 105. Abbott Laboratories SWOT Analysis
Table 106. Abbott Laboratories Recent Developments
Table 107. Agilent Technologies Basic Information
Table 108. Agilent Technologies Personalized Medicine Product Overview
Table 109. Agilent Technologies Personalized Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Agilent Technologies Business Overview
Table 111. Agilent Technologies SWOT Analysis
Table 112. Agilent Technologies Recent Developments
Table 113. Amgen Basic Information
Table 114. Amgen Personalized Medicine Product Overview
Table 115. Amgen Personalized Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Amgen Business Overview
Table 117. Amgen SWOT Analysis
Table 118. Amgen Recent Developments
Table 119. Astellas Pharma Basic Information
Table 120. Astellas Pharma Personalized Medicine Product Overview
Table 121. Astellas Pharma Personalized Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Astellas Pharma Business Overview
Table 123. Astellas Pharma Recent Developments
Table 124. Astrazeneca Basic Information
Table 125. Astrazeneca Personalized Medicine Product Overview
Table 126. Astrazeneca Personalized Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Astrazeneca Business Overview
Table 128. Astrazeneca Recent Developments
Table 129. Bayer AG Basic Information
Table 130. Bayer AG Personalized Medicine Product Overview
Table 131. Bayer AG Personalized Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Bayer AG Business Overview
Table 133. Bayer AG Recent Developments
Table 134. Celgene Corporation Basic Information
Table 135. Celgene Corporation Personalized Medicine Product Overview
Table 136. Celgene Corporation Personalized Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Celgene Corporation Business Overview
Table 138. Celgene Corporation Recent Developments
Table 139. Glaxosmithkline Plc Basic Information
Table 140. Glaxosmithkline Plc Personalized Medicine Product Overview
Table 141. Glaxosmithkline Plc Personalized Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Glaxosmithkline Plc Business Overview
Table 143. Glaxosmithkline Plc Recent Developments
Table 144. Illumina Basic Information
Table 145. Illumina Personalized Medicine Product Overview
Table 146. Illumina Personalized Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Illumina Business Overview
Table 148. Illumina Recent Developments
Table 149. Johnson and Johnson Basic Information
Table 150. Johnson and Johnson Personalized Medicine Product Overview
Table 151. Johnson and Johnson Personalized Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. Johnson and Johnson Business Overview
Table 153. Johnson and Johnson Recent Developments
Table 154. Laboratory Corporation Basic Information
Table 155. Laboratory Corporation Personalized Medicine Product Overview
Table 156. Laboratory Corporation Personalized Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 157. Laboratory Corporation Business Overview
Table 158. Laboratory Corporation Recent Developments
Table 159. Merck Basic Information
Table 160. Merck Personalized Medicine Product Overview
Table 161. Merck Personalized Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 162. Merck Business Overview
Table 163. Merck Recent Developments
Table 164. Novartis AG Basic Information
Table 165. Novartis AG Personalized Medicine Product Overview
Table 166. Novartis AG Personalized Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 167. Novartis AG Business Overview
Table 168. Novartis AG Recent Developments
Table 169. Roche Holding AG Basic Information
Table 170. Roche Holding AG Personalized Medicine Product Overview
Table 171. Roche Holding AG Personalized Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 172. Roche Holding AG Business Overview
Table 173. Roche Holding AG Recent Developments
Table 174. Siemens AG Basic Information
Table 175. Siemens AG Personalized Medicine Product Overview
Table 176. Siemens AG Personalized Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 177. Siemens AG Business Overview
Table 178. Siemens AG Recent Developments
Table 179. Takeda Pharmaceutical Company Limited Basic Information
Table 180. Takeda Pharmaceutical Company Limited Personalized Medicine Product Overview
Table 181. Takeda Pharmaceutical Company Limited Personalized Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 182. Takeda Pharmaceutical Company Limited Business Overview
Table 183. Takeda Pharmaceutical Company Limited Recent Developments
List of Figures
Figure 1. Product Picture of Personalized Medicine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Personalized Medicine Market Size (M USD), 2024-2033
Figure 5. Global Personalized Medicine Market Size (M USD) (2020-2033)
Figure 6. Global Personalized Medicine Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Personalized Medicine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Personalized Medicine Product Life Cycle
Figure 13. Personalized Medicine Sales Share by Manufacturers in 2024
Figure 14. Global Personalized Medicine Revenue Share by Manufacturers in 2024
Figure 15. Personalized Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Personalized Medicine Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Personalized Medicine Revenue in 2024
Figure 18. Industry Chain Map of Personalized Medicine
Figure 19. Global Personalized Medicine Market PEST Analysis
Figure 20. Global Personalized Medicine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Personalized Medicine Market Size by Region
Figure 27. Global Personalized Medicine Market Size Market Share by Region (2020-2033)
Figure 28. Global Personalized Medicine Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Personalized Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 31. North America Personalized Medicine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Personalized Medicine Market Size (M USD) by Country
Figure 33. USA Personalized Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 34. USA Personalized Medicine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Personalized Medicine Sales (K Units) and Growth Rate (2020-2033)
Figure 36. Canada Personalized Medicine Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Personalized Medicine Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Personalized Medicine Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Personalized Medicine Market Size (M USD)by Type
Figure 40. North America Personalized Medicine Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Personalized Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 43. Europe Personalized Medicine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Personalized Medicine Market Size (M USD) by Country
Figure 45. Germany Personalized Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 46. Germany Personalized Medicine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Personalized Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 48. France Personalized Medicine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Personalized Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 50. U.K. Personalized Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Personalized Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 52. Italy Personalized Medicine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Personalized Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 54. Spain Personalized Medicine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Personalized Medicine Market Size (M USD) by Type
Figure 56. Europe Personalized Medicine Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Personalized Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 59. Asia-Pacific Personalized Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Personalized Medicine Market Size (M USD) by Country
Figure 61. China Personalized Medicine Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. China Personalized Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Personalized Medicine Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Japan Personalized Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Personalized Medicine Sales and Growth Rate (2020-2025) & (K Units)
Figure 66. South Korea Personalized Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Personalized Medicine Sales and Growth Rate (2020-2025) & (K Units)
Figure 68. India Personalized Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Personalized Medicine Sales and Growth Rate (2020-2025) & (K Units)
Figure 70. Southeast Asia Personalized Medicine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Personalized Medicine Market Size (M USD) by Type
Figure 72. Asia-Pacific Personalized Medicine Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Personalized Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 75. South America Personalized Medicine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Personalized Medicine Market Size (M USD) by Country
Figure 77. Brazil Personalized Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 78. Brazil Personalized Medicine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Personalized Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 80. Argentina Personalized Medicine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Personalized Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 82. Columbia Personalized Medicine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Personalized Medicine Market Size (M USD) by Type
Figure 84. South America Personalized Medicine Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Personalized Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 87. Middle East and Africa Personalized Medicine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Personalized Medicine Market Size (M USD) by Country
Figure 89. Saudi Arabia Personalized Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 90. Saudi Arabia Personalized Medicine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Personalized Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 92. UAE Personalized Medicine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Personalized Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 94. Egypt Personalized Medicine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Personalized Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 96. Nigeria Personalized Medicine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Personalized Medicine Sales and Growth Rate (2020-2033) & (K Units)
Figure 98. South Africa Personalized Medicine Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Personalized Medicine Market Size (M USD) by Type
Figure 100. Middle East and Africa Personalized Medicine Market Size (M USD) by Application
Figure 101. Global Personalized Medicine Production Market Share by Region (2020-2025)
Figure 102. North America Personalized Medicine Production (K Units) Growth Rate (2020-2025)
Figure 103. Europe Personalized Medicine Production (K Units) Growth Rate (2020-2025)
Figure 104. Japan Personalized Medicine Production (K Units) Growth Rate (2020-2025)
Figure 105. China Personalized Medicine Production (K Units) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Personalized Medicine Market Size by Type (M USD)
Figure 108. Sales Market Share of Personalized Medicine by Type (2020-2033)
Figure 109. Sales Market Share of Personalized Medicine by Type in 2024
Figure 110. Market Size Share of Personalized Medicine by Type (2020-2033)
Figure 111. Market Size Share of Personalized Medicine by Type in 2024
Figure 112. Global Personalized Medicine Price (USD/Unit) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Personalized Medicine Market Size by Application(M USD)
Figure 115. Global Personalized Medicine Market Share by Application
Figure 116. Global Personalized Medicine Sales Market Share by Application (2020-2033)
Figure 117. Global Personalized Medicine Sales Market Share by Application in 2024
Figure 118. Global Personalized Medicine Market Share by Application (2020-2033)
Figure 119. Global Personalized Medicine Market Share by Application in 2024
Figure 120. Global Personalized Medicine Sales Growth Rate by Application (2020-2033)


More Publications